Clinical Trials in New York

Showing 3921-3940 of 22,668 trials

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

NCT06680427

The Siegel™ Transcatheter Aortic Valve (TAVR) early feasibility study objective is to assess the acute and long-term safety and feasibility of the Siegel TAVR device in adult subjects with symptomatic, severe native aortic stenosis eligible for the transcatheter aortic valve replacement.

Aortic Stenosis Symptomatic

MiRus30 participantsStarted Mar 2025

Los Angeles, California, United States • Palo Alto, California, United States • Naples, Florida, United States +5 more locations

Active Not RecruitingPhase 2< 1 mile

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

NCT03897881

The purpose of this study is to assess whether postoperative adjuvant therapy with mRNA-4157 and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma and a high risk of recurrence.

Melanoma

ModernaTX, Inc.267 participantsStarted Jul 2019

Tucson, Arizona, United States • San Francisco, California, United States • Santa Monica, California, United States +20 more locations

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Find Trials by Condition in New York

Pediatric Parenting Support in Flint

CNGB1 and Allied Disorders

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

Risk Stratification Among Individuals Who Have Many Moles on Their Skin

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

PAS-004 in Patients With Advanced Solid Tumors

Stellate Ganglion Block for PTSD

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis